MD
University of Pennsylvania
Disclosure(s): Merck: Honoraria; Shionogi: Honoraria; Viiv: Honoraria
Dr. Pablo Tebas is a Professor of Medicine in the Division of Infectious Diseases at the Hospital of the University of Pennsylvania. He serves as Director and Principal Investigator of the AIDS Clinical Trials Unit (ACTU) and as an investigator in the Vaccine Trials Network at Penn. His work focuses on the design and conduct of early-phase clinical trials evaluating novel strategies for the prevention, treatment, and cure of HIV infection.
Over the past three decades, Dr. Tebas has led and collaborated on numerous studies involving antiretroviral therapy, gene- and vector-based immunotherapies, and therapeutic vaccination approaches. His current research explores the use of DNA-encoded monoclonal antibodies and latency-reversing agents to address persistent HIV reservoirs. He has played a key role in translating laboratory discoveries into first-in-human clinical trials and in mentoring the next generation of clinical investigators committed to infectious disease research.